Celcuity, Inc. (CELC) Now Covered by Craig Hallum

Craig Hallum started coverage on shares of Celcuity, Inc. (NASDAQ:CELC) in a research note issued to investors on Monday morning, The Fly reports. The brokerage issued a buy rating on the stock.

Shares of Celcuity (CELC) opened at 16.23 on Monday. The firm’s market capitalization is $157.79 million. The firm’s 50-day moving average is $13.75 and its 200 day moving average is $13.75. Celcuity has a 52 week low of $11.10 and a 52 week high of $16.50.

TRADEMARK VIOLATION NOTICE: “Celcuity, Inc. (CELC) Now Covered by Craig Hallum” was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.thestockobserver.com/2017/10/20/celcuity-inc-celc-now-covered-by-craig-hallum.html.

Celcuity Company Profile

Celcuity, Inc is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it.

The Fly

Receive News & Ratings for Celcuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply